PRISMASOL 2
PRISMASOL 2
Dormant
DIN Number
02277441
Drug Class
Human
Market Date
Feb 21, 2006
Company
HC
Vantive ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02277441
AIG Number0752650003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05ZA HEMODIALYTICS, CONCENTRATES
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
,
Haemodialysis
AHFS Classification40:34.00*
Health Canada Classification
ACTIVE INGREDIENTS (7)
CALCIUM CHLORIDEActive
Strength: 5.145 G / L
Monograph: CALCIUM CHLORIDE
DEXTROSE ANHYDROUSActive
Strength: 22 G / L
Monograph: DEXTROSE ANHYDROUS
L-LACTIC ACIDActive
Strength: 5.4 G / L
Monograph: L-LACTIC ACID
MAGNESIUM CHLORIDEActive
Strength: 2.033 G / L
Monograph: MAGNESIUM CHLORIDE
POTASSIUM CHLORIDEActive
Strength: 0.157 G / L
Monograph: POTASSIUM CHLORIDE
SODIUM BICARBONATEActive
Strength: 3.09 G / L
Monograph: SODIUM BICARBONATE
SODIUM CHLORIDEActive
Strength: 6.45 G / L
Monograph: SODIUM CHLORIDE